EFFECT OF LOW-MOLECULAR-WEIGHT HEPARAN-SULFATE ON ANGIOGENESIS IN THE RAT CORNEA AFTER CHEMICAL CAUTERIZATION

被引:40
作者
LEPRI, A [1 ]
BENELLI, U [1 ]
BERNARDINI, N [1 ]
BIANCHI, F [1 ]
LUPETTI, M [1 ]
DANESI, R [1 ]
DELTACCA, M [1 ]
NARDI, M [1 ]
机构
[1] UNIV PISA,INST OPHTHALMOL,I-56126 PISA,ITALY
来源
JOURNAL OF OCULAR PHARMACOLOGY | 1994年 / 10卷 / 01期
关键词
D O I
10.1089/jop.1994.10.273
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Vascularization of the cornea occurs in many pathological conditions and can result in loss of visual acuity. It is also thought that vascularization predisposes the cornea to reject grafts by facilitating the detection of foreign antigens in donor material. A rat corneal assay for angiogenesis was adopted in the present study to evaluate the possible angiostatic activity of a low molecular weight heparan sulphate (LMW-HS). Corneal lesions were induced by chemical cauterization at 2 mm from the corneoscleral limbus. Rats were randomized to receive two drops/eye four times daily, for 6 days, of a solution of LMW-HS in vehicle (2.5% carboxymethylcellulose), heparin, heparin plus hydrocortisone, or vehicle alone. After a 6 day-treatment period, the eyes were perfused with india ink and the degree of neovascularization was evaluated. In rats treated with vehicle alone a dense vascular network extending from the corneoscleral limbus to the cauterized site was observed; on the contrary, a markedly reduced vascular network was evidenced in animals treated with LMW-HS. The distribution of basic fibroblast growth factor (bFGF) in the cauterized cornea was also evaluated by using an immunohistochemical method. A marked bFGF immunoreactivity was demonstrated in corneal epithelium and stroma of control rats 12-48 hours after the cautery. These results lead to the assumption that LMW-HS could be used in ophthalmology to inhibit corneal neovascularization.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 32 条
[1]  
McCracken J.S., Burger P.C., Klintworth G.K., Morphologic observations on experimental corneal vascularization in the rat, Lab. Invest., 41, pp. 519-530, (1979)
[2]  
Lipman R.M., Epstein R.J., Hendricks R.L., Suppression of corneal neovascularization with cyclosporine, Arch. Ophthalmol., 110, pp. 405-407, (1992)
[3]  
Epstein R.J., Stulting R.D., Hendricks R.L., Harris D.M., Corneal neovascularization: pathogenesis and inhibition, Cornea, 6, pp. 250-258, (1987)
[4]  
Nirankari V.S., Dandona L., Rodrigues M.M., Laser photocoaugulation of experimental corneal stromal vascularization. Efficacy and histopathology, Ophthalmology, 100, pp. 111-118, (1993)
[5]  
Frucht J., Zauberman H., Topical indomethacin effect on neovascularization of the cornea and on prostaglandin E2 levels, Br. J. Ophthalmol., 68, pp. 656-659, (1984)
[6]  
Li W.W., Casey R., Gonzalez E.M., Folkman J., Angiostatic steroids potentiated by sulphated cyclodextrins inhibit corneal neovascularization, Invest. Ophthalmol. Vis. Sci., 32, pp. 2898-2905, (1991)
[7]  
Folkman J., Klagsbrun M., Angiogenic factors, Science, 235, pp. 442-447, (1987)
[8]  
Sunderkotter C., Roth J., Sorg C., Immunoistochemical detection of bFGF and TNF-α in the course of inflammatory angiogenesis in the mouse cornea, Am. J. Pathol., 137, pp. 511-515, (1990)
[9]  
Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Einer V.M., Einer S.G., Strieter R.M., Interleukin-8 as a macrophage-derived Mediator of angiogenesis, Science, 258, pp. 1798-1801, (1992)
[10]  
Risau W., Angiogenic growth factors, Prog. Grow. Factor Res., 2, pp. 71-79, (1990)